山東路橋(000498.SZ):擬公開發行3億元公司債券
格隆匯5月25日丨山東路橋(000498.SZ)發佈2021年面向專業投資者公開發行公司債券(第一期)發行公吿,發行規模為人民幣3億元,債券簡稱為“21山路01”,本期債券期限為5年,附第3年末發行人調整票面利率選擇權和投資者回售選擇權。
本期債券的詢價區間為3.30%-4.30%,發行人和主承銷商將於2021年5月27日向投資者進行簿記詢價,並根據詢價情況確定本期債券的最終票面利率。發行人和主承銷商將於2021年5月28日公吿本期債券的最終票面利率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.